![]() ![]() Furthermore, new research presented at ECR demonstrates how ProFound AI helps to improve radiologists’ workflow and efficiency.”Įmily F. Specifically, this high-performing deep learning technology offers marked improvements in sensitivity and specificity and a reduction in the rate of false positives, which can reduce unnecessary callbacks for patients. “ProFound AI empowers doctors to find breast cancers earlier, when they may be more easily treated. “iCAD’s powerful artificial intelligence (AI) solutions are clinically proven to offer unparalleled benefits to both clinicians and patients,” said Michael Klein, Chairman and CEO of iCAD. During the congress, the Company also showcased the full suite of its Breast Health Solutions in the virtual iCAD booth (#1608), including ProFound AI Risk, the world’s first commercially available clinical decision support tool that provides a highly accurate short-term risk estimation specific to each woman based on data from a screening mammogram. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced new research supporting ProFound AI® was presented at the European Congress of Radiology (ECR) 2021 Online meeting, taking place March 3-10, 2021. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |